Skip to content
Dose Brief
Menu
No. 199 on the board · Grade C

Claya review

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

Visit Claya Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $179/mo (starting dose, compounded)
Tirzepatide
From $279/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $179/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Claya scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability75/100
Transparency72/100
Access Breadth56/100
Clinical Oversight82/100
Track Record73/100

What we like

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

The caveats

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

The brief

Best for: Readers who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians. Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

Ranked #199 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest Claya — the realistic shortlist if you're weighing it.

Weighing Claya against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs Claya, and every desk that outranks it is listed on the Claya alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect Claya's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Claya's site. Not medical advice; see our disclosure.

← Back to all rankings